Publications

Kristian Brock (2020). Pembrolizumab in patients with non-small-cell lung cancer of performance status 2 (PePS2) - a single arm, phase 2 trial. Lancet Respiratory Medicine.

PDF Project DOI Article

Kristian Brock, Lucinda Billingham, Christina Yap, Gary Middleton (2019). A Phase II Clinical Trial Design for Associated Co-primary Efficacy and Toxicity Outcomes with Baseline Covariates. Springer: Bayesian Statistics and New Generations.

PDF Project DOI Article

Kristian Brock (2019). Ibrutinib Plus Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia - The CLARITY Study. Journal of Clinical Oncology.

PDF DOI Article

Kristian Brock (2019). trialr - Bayesian Clinical Trial Designs in R and Stan.

PDF Code Project Video Source Document CRAN package arXiv

Graham Wheeler, Adrian Mander, Alun Bedding, Kristian Brock, Victoria Cornelius, Andrew Grieve, Thomas Jaki, Sharon Love, Lang’o Odondi, Christopher Weir, Christina Yap, Simon Bond (2019). How to design a dose-finding study using the continual reassessment method. BioMed Central: Medical Research Methodology.

PDF DOI Article

Charles Craddock, Daniel Slade, Carmela De Santo, Rachel Wheat, Paul Ferguson, Andrea Hodgkinson, Kristian Brock, Jamie Cavenagh, Wendy Ingram, Mike Dennis, Ram Malladi, Shamyla Siddique, Francis Mussai, Christina Yap (2019). Combination Lenalidomide and Azacitidine - A Novel Salvage Therapy in Patients Who Relapse After Allogeneic Stem-Cell Transplantation for Acute Myeloid Leukemia. Journal of Clinical Oncology.

PDF DOI Article

Kristian Brock, Lucinda Billingham, Mhairi Copland, Shamyla Siddique, Mirjana Sirovica, Christina Yap (2017). Implementing the EffTox dose-finding design in the Matchpoint trial. BioMed Central: Medical Research Methodology.

PDF DOI Article